Pharmafile Logo
Pharmafocus logo
Advanced Search

Hemlibra

Showing 9 posts of 9 posts found.

blood-1813410_960_720

NHS England to fund Hemlibra for patients with severe haemophilia

August 21, 2019
Research and Development Chugai, Hemlibra, Roche, haemophilia, pharma

NHS England is to fund Roche and Chugai Pharma UK’s haemophilia drug Hemlibra, for people with sever congenital haemophilia A …

News
roche_dark_0

Roche and Chugai’s Hemlibra scoops up EU approval in the prevention of severe haemophilia A without factor VIII inhibitors

March 14, 2019
Sales and Marketing Chugai, Hemlibra, Roche, haemophilia, pharma

Roche has announced along with its partner Chugai that Hemlibra (emicizumab) has secured approval from the European Commission as a …

News
shutterstock_243110086

Hemlibra shows “clinically meaningful” bleed control in paediatric haemophilia A patients

December 4, 2018
Manufacturing and Production, Research and Development ASH 2018, Hemlibra, Roche, haemophilia, pharma

In another reveal at the American Society of Hematology (ASH) Annual Meeting 2018, Roche unveiled new Phase 3 findings for …

News
roche_dark_0

FDA expands indication of Roche’s Hemlibra in haemophilia

October 5, 2018
Medical Communications, Sales and Marketing Hemlibra, Roche, haemophilia, pharma

The FDA has chosen to expand the label of Roche’s Hemlibra (emicizumab-kxwh), approving it for routine prophylaxis to prevent the …

News
roche

Roche’s Hemlibra stakes claim to be haemophilia market leader

May 21, 2018
Research and Development, Sales and Marketing Hemlibra, Roche, Shire, biotech, drugs, haemophilia, pharma, pharmaceutical

Hemlibra was widely expected to become the dominant therapeutic for treating haemophilia patients and its latest clinical trial results only …

News
4420456374_64a3d7e6aa

Top Ten most popular articles on Pharmafile.com this week

March 29, 2018
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Ablynx, Cancer, GSK, Hemlibra, MSD, Roche, Sun Pharma, Takeda, brexit, pharma, tecentriq, top ten

As we approach the Easter weekend, we at Pharmafocus hope all of our readers have a great long weekend, if …

News
genentechlr_copy

Five deaths linked to Roche’s haemophilia drug Hemlibra

March 28, 2018
Research and Development Genentech, Hemlibra, Roche, haemophilia, pharma

Roche has been rocked by the revelation that there have been five patient deaths linked to the use of its …

News

Europe approves first therapy for haemophilia A with inhibitors in over 20 years

March 1, 2018
Research and Development Europe, European Commission, Hemlibra, Roche, haemophilia, pharma

Roche has revealed that its bispecific factor IXa- and factor X-directed antibody Hemlibra (emicizumab) has been approved by the European …

News

Roche’s haemophillia A treatment gets nod but with black box warning

November 17, 2017
Medical Communications, Sales and Marketing Hemlibra, Roche, biotech, drugs, pharma, pharmaceutical

Roche needs its pipeline to pick up quick successes, with its big earners are looking at precipitous patent cliffs, and, …

News

Latest content

Tolremo doses first patient in phase 1 trial for drug to combat transcriptional cancer drug resistance

November 29, 2023

FDA grants breakthrough device designation to Inflammatix’s TriVerity Acute Infection and Sepsis Test System

November 29, 2023

FDA accepts new drug application for Orexo’s opioid overdose medication

November 28, 2023

Arcturus Therapeutics gains FDA ODD for cystic fibrosis treatment

November 28, 2023

Sanofi and Regeneron share results from phase 3 trial for Dupixent as COPD treatment

November 27, 2023